Ebastine

Trade name: kestine

Small moleculeexperimental

Ebastine is a H1 antihistamine with low potential for causing drowsiness. — Wikipedia

Clinical trial activity

4 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
3

Earliest trial started Oct 1, 2009 (NCT01144832)

Timeline

No events for the selected filters.

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1
Mol. weight
469.67 g/mol
Lipinski Ro5
1 violation(s)
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No
Delivery
Oral

Oral

Yes

Parenteral

No

Topical

No

Sources

Also known as

  • 4-diphenylmethoxy-1-(3-(4-tert-butylbenzoyl)propyl)piperidine
  • bactil
  • bastel
  • busidril
  • ebastel
  • ebastel
  • ebastin
  • ebastine
  • ebastine
  • ebastine
  • ebastine
  • ebastine
  • ebastine
  • ebastine
  • ebastine
  • erostin
  • evastel
  • kestin
  • kestine
  • kestine
  • kestine
  • kestine
  • las w-090
  • las w-090
  • las w-090
  • rp-64305
  • rp-64305

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01908465Phase 4Nov 1, 2013Katholieke Universiteit Leuven
NCT01940393Phase 4Aug 1, 2013Grupo de Alergología Clínica y Experimental, Universidad de Antioquia
NCT02065440N/ASep 1, 2011Seoul National University
NCT01144832Phase 4Oct 1, 2009Katholieke Universiteit Leuven
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Katholieke Universiteit LeuvenAcademic/Hospital2212009
Grupo de Alergología Clínica y ExperimentalAcademic/Hospital1112013
Seoul National UniversityAcademic/Hospital1112011
Universidad de AntioquiaAcademic/Hospital1012013
4 organizations
Page 1 / 1